[Federal Register Volume 60, Number 196 (Wednesday, October 11, 1995)]
[Notices]
[Page 52923]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-25076]



=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 17, 1995, Ciba-Geigy 
Corporation, Pharmaceuticals Division Regulatory Compliance, 556 Morris 
Avenue, Summit, New Jersey 07901, made application to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the Schedule II controlled substance Methylphenidate 
(1724).
    The firm plans to manufacture the finished product for distribution 
to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed to the Deputy 
Assistant Administrator, Office of Diversion Control, Drug Enforcement 
Administration, United States Departments of Justice, Washington, D.C. 
20537, Attention: DEA Federal Register Representative (CCR), and must 
be filed no later than December 11, 1995.

    Dated: September 29, 1995.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 95-25076 Filed 10-10-95; 8:45 am]
BILLING CODE 4410-09-M